AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Torglip M 50/850 Tablet

Prescription Icon
Prescription Required

Marketer

Torrent Pharmaceuticals Ltd

Salt Composition

Metformin (850mg) + Vildagliptin (50mg)

Overview Torglip M 50/850 Tablet

Combiplus 50/850mg tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent serious diabetic complications like kidney failure and vision loss, and may lower the risk of cardiovascular events such as heart attacks and strokes. Combiplus 50/850mg may be used independently or in conjunction with other anti-diabetic therapies. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering current health status, blood sugar readings, and other concurrent medications. Consuming the tablet with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under medical guidance. Effective blood sugar control contributes to preventing future serious complications. Continued commitment to the physician-recommended diet and exercise plan is crucial for successful diabetes management, as lifestyle significantly impacts blood sugar levels. Common side effects include nausea, vomiting, diarrhea, stomach upset, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential adverse effect, particularly when combined with insulin or sulfonylureas; therefore, understanding hypoglycemia recognition and management is essential. This medication isn't universally suitable. Prior to commencing treatment, inform your doctor of any history of kidney, liver, or heart disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating women should seek medical counsel before use. Potential drug interactions exist; disclose all medications to your physician to ensure treatment safety. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Your physician will monitor kidney function and blood glucose levels throughout the treatment period.

Uses of Torglip M 50/850 Tablet

Managing type 2 diabetes

Major Benefits of Torglip M 50/850 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Torglip M 50/850 Tablet with a meal.

Common Side effects of Torglip M 50/850 Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Torglip M 50/850 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Torglip M 50/850 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Torglip M 50/850 Tablet works:

Torglip M 50/850 tablets contain a dual antidiabetic medication formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Torglip M 50/850 Tablet with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Torglip M 50/850 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Torglip M 50/850 tablets while breastfeeding is likely inadvisable. Available data from human studies indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Individuals with kidney impairment should exercise caution when using Torglip M 50/850 Tablets. Dosage modification may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Patients with liver conditions should likely avoid Torglip M 50/850 Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Torglip M 50/850 Tablet :

Should you forget a Torglip M 50/850 Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Torglip M 50/850 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Torglip M 50/850 Tablet

Torglip M 50/850 Tablets rarely cause hypoglycemia by themselves, but this can happen if you don't consume enough calories. Symptoms of low blood sugar include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness. These are more likely if you skip meals, drink alcohol, overexert yourself, or take other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always keep glucose tablets, honey, or fruit juice readily available.
Nausea and vomiting are possible side effects of Torglip M 50/850 Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) require immediate medical attention. Consult your doctor before taking any other medication.
Torglip M 50/850 Tablets are contraindicated in patients with allergies to any ingredient or excipient. This medication should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication safely and ensure it remains inaccessible to children, pets, and others.
Torglip M 50/850 Tablet combines the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Torglip M 50/850 Tablet can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). While rare, this risk is higher in patients with kidney disease, the elderly, or those consuming large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Torglip M 50/850 Tablet and seek immediate medical attention.
Prolonged Torglip M 50/850 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia and neurological complications.
Torglip M 50/850 Tablet is safe when taken as prescribed. However, even with correct usage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (especially if used with insulin or sulphonylurea) may occur. Report any persistent issues to your doctor.
Torglip M 50/850 Tablet
87
MRP 101
13% off